These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 2499663

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N.
    Cancer; 1996 Sep 15; 78(6):1300-7. PubMed ID: 8826954
    [Abstract] [Full Text] [Related]

  • 11. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
    Weiner LM, Moldofsky PJ, Gatenby RA, O'Dwyer J, O'Brien J, Litwin S, Comis RL.
    Cancer Res; 1988 May 01; 48(9):2568-73. PubMed ID: 3128400
    [Abstract] [Full Text] [Related]

  • 12. Biologic modulation of 5-fluorouracil with high-dose leucovorin and combination chemotherapy of 5-fluorouracil and cisplatin in metastatic colorectal adenocarcinoma.
    Petrelli NJ, Madajewicz S, Herrera L, Rustum YM, Trave F, Creaven P, Mittelman A.
    NCI Monogr; 1987 May 01; (5):189-92. PubMed ID: 3501541
    [Abstract] [Full Text] [Related]

  • 13. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A.
    Srp Arh Celok Lek; 1998 May 01; 126(9-10):355-61. PubMed ID: 9863407
    [Abstract] [Full Text] [Related]

  • 14. [Phase I study of the combination of nedaplatin (NED), adriamycin (ADM), and 5-fluorouracil (5-FU) (NAF) for treatment of unresectable advanced esophageal cancer].
    Hirao M, Fujitani K, Tsujinaka T.
    Gan To Kagaku Ryoho; 2005 Jan 01; 32(1):53-6. PubMed ID: 15675582
    [Abstract] [Full Text] [Related]

  • 15. The activity of paclitaxel in gastrointestinal tumors.
    Ajani JA, Ilson DH, Kelsen DP.
    Semin Oncol; 1995 Oct 01; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861
    [Abstract] [Full Text] [Related]

  • 16. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
    Schwartzberg LS, Petak I, Stewart C, Turner PK, Ashley J, Tillman DM, Douglas L, Tan M, Billups C, Mihalik R, Weir A, Tauer K, Shope S, Houghton JA.
    Clin Cancer Res; 2002 Aug 01; 8(8):2488-98. PubMed ID: 12171874
    [Abstract] [Full Text] [Related]

  • 17. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A.
    Cancer; 1999 Jan 15; 85(2):290-4. PubMed ID: 10023694
    [Abstract] [Full Text] [Related]

  • 18. A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity.
    Abbruzzese JL, Levin B, Ajani JA, Faintuch JS, Pazdur R, Saks S, Edwards C, Gutterman JU.
    J Biol Response Mod; 1990 Oct 15; 9(5):522-7. PubMed ID: 2123922
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of combined effects of gamma-interferon and 5-fluorouracil on human colon cancers implanted into nude mice.
    Morikawa K, Fan D, Denkins YM, Levin B, Gutterman JU, Walker SM, Fidler IJ.
    Cancer Res; 1989 Feb 15; 49(4):799-805. PubMed ID: 2492206
    [Abstract] [Full Text] [Related]

  • 20. Phase II study of melphalan in colorectal carcinoma.
    DiBenedetto J, Moayeri H, Evans JT, Mittelman A.
    Cancer Treat Rep; 1978 Sep 15; 62(9):1401-2. PubMed ID: 688286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.